Related Subjects:
|Fever in a traveller
|Malaria Falciparum
|Malaria Non Falciparum
|Viral Haemorrhagic Fevers (VHF)
|Lassa fever
|Dengue
|Marburg virus disease
|AIDS HIV
|Yellow fever
|Ebola Virus
|Leptospirosis
| Crimean-Congo haemorrhagic fever
|African Trypanosomiasis (Sleeping sickness)
|American Trypanosomiasis (Chagas Disease)
|Incubation Periods
|Notifiable Diseases UK
Leptospirosis is transmitted through the urine of infected animals, most commonly rats, mice, cows, pigs, and dogs. Antibiotics should be started based on clinical suspicion before cultures are available.
About
- Leptospirosis is a zoonotic infection caused by the bacterium Leptospira interrogans.
Pathology
- The bacteria live in the renal tubules of chronically infected asymptomatic mammals.
- Leptospires are shed in the urine of infected animals and can survive in shaded, warm, and humid environments for weeks to months.
Risks
- High-risk groups include animal workers, sewage workers, and those involved in water sports.
- Transmission via pets and animal bites is rare.
- Human-to-human transmission is extremely uncommon.
Aetiology
- Caused by gram-negative, coiled bacteria with hooked ends.
- Leptospira bacteria gain entry through mucous membranes or broken skin.
Hosts
- Rats (Rattus Norvegicus): A major reservoir, shedding large quantities of leptospires in their urine.
Clinical Presentation
- Symptoms typically appear 1-2 weeks after exposure.
- Fever with conjunctival suffusion: Hyperemia of the conjunctiva is a useful sign.
- Renal failure: Oliguria, proteinuria, haematuria, and renal casts.
- Hepatosplenomegaly and jaundice: Liver involvement without classic liver failure or encephalopathy.
- Pulmonary syndrome: In severe cases, ARDS, multi-organ failure, and pulmonary haemorrhage (seen more frequently in Asia).
- Bleeding manifestations: Bruising, epistaxis, haematemesis, melaena, and pleural or pericardial effusions.
- Aseptic meningitis resembling viral meningitis.
- Other complications: Myocarditis, encephalitis.
Classical Presentations
- Mild influenza-like illness.
- Weil's Syndrome: Jaundice, renal failure, haemorrhage, and myocarditis with arrhythmias.
- Meningitis or meningoencephalitis.
- Pulmonary haemorrhage with respiratory failure.
Differential Diagnosis
- Dengue, Typhoid fever, Malaria, Scrub typhus, Hantavirus.
Investigations
- FBC: Decreased platelets, elevated WCC (neutrophilia).
- U&E: Raised creatinine, proteinuria, and haematuria.
- LFTs: Raised AST, ALT, bilirubin, and CK; prolonged PT.
- LP/CSF: Elevated protein, normal glucose.
- Culture: Blood cultures are positive before day 10; urine cultures become positive after 7 days.
- Serology: Positive IgM after the first week. Treat based on clinical suspicion.
- PCR: Can detect leptospiral DNA in blood or urine (most useful after day 8).
Prevention
- Wash hands after handling animals or animal products; clean wounds immediately.
- Cover cuts and grazes with waterproof plasters.
- Wear protective clothing if at risk (e.g., occupational exposure).
- Avoid contact with potentially contaminated water; shower after exposure.
- Vaccinate dogs (no vaccine is available for humans).
- Boil untreated water from rivers, canals, or lakes before consumption.
Complications
- Acute renal failure leading to oliguric AKI.
- Severe pulmonary haemorrhage, potentially requiring mechanical ventilation.
- Aseptic meningitis, ARDS, haemolytic anaemia, Guillain-Barré syndrome, and circulatory collapse.
Management
- Supportive care is the mainstay of treatment; the disease is usually self-limiting.
- Transfusions for significant haemorrhage may be necessary.
- Renal support or replacement therapy may be life-saving; AKI typically resolves.
Antibiotic Therapy
- Severe disease: IV Benzylpenicillin 1.5 MU every 6 hours for 1 week, or Ceftriaxone 1 g daily for 1 week.
- Mild disease: Oral Doxycycline 100 mg twice daily for 1 week.
- A mild Jarisch-Herxheimer reaction may occur with penicillin therapy. Mortality rate remains high (>10%) in severe cases.
Prevention in High-Risk Individuals
- Doxycycline 200 mg weekly can be protective in high-risk individuals.